Cusago, Italy

Gabriella Maria Brasca

This inventor holds 1 USPTO granted patent. Top assignee: Pharmacia Corporation. Active years: 1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gabriella Maria Brasca. Retrieved from https://idiyas.com/inventor/gabriella-maria-brasca

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 1998

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Gabriella Maria Brasca: Innovator in Pharmaceutical Compounds

Introduction

Gabriella Maria Brasca is a notable inventor based in Cusago, Italy. She has made significant contributions to the field of pharmaceuticals, particularly through her innovative work on chemical compounds.

Latest Patents

Gabriella holds a patent for "Substituted 3-arylidene-7-azaoxindole compounds and process for their." This patent showcases her expertise in developing new chemical entities that may have therapeutic applications.

Career Highlights

Gabriella is currently employed at Pharmacia S.p.a., where she continues to advance her research and development efforts. Her work at this esteemed company has allowed her to focus on creating impactful pharmaceutical solutions.

Collaborations

Throughout her career, Gabriella has collaborated with esteemed colleagues such as Franco Buzzetti and Antonio Longo. These partnerships have enriched her research and contributed to her success in the field.

Conclusion

Gabriella Maria Brasca is a pioneering inventor whose work in pharmaceutical compounds exemplifies innovation and dedication. Her contributions continue to influence the industry and inspire future advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…